Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
LataMed AILMEDD +13.78%26 Market Cap is $1,574.42 Mil as of Jul. 17, 2026. GuruFocus rates LMEDD with a GF Score™ of 26/100. The stock has 3 warning signs investors should review. Among 2,932 Software companies, LataMed AI ranks better than 87.18% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). LataMed AI's share price for the quarter that ended in Mar. 2026 was $0.244. LataMed AI's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 280.67 Mil. Therefore, LataMed AI's market cap for the quarter that ended in Mar. 2026 was $68.48 Mil.
LataMed AI's quarterly market cap
increased
from Sep. 2025 ($22.25 Mil) to Dec. 2025 ($28.80 Mil) and
increased
from Dec. 2025 ($28.80 Mil) to Mar. 2026 ($68.48 Mil).
LataMed AI's annual market cap
declined
from Dec. 2023 ($19.73 Mil) to Dec. 2024 ($11.83 Mil) but then
increased
from Dec. 2024 ($11.83 Mil) to Dec. 2025 ($28.80 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. LataMed AI's Enterprise Value for Today is $130.63 Mil.
LataMed AI (OTCPK:LMEDD) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
LataMed AI Market Cap Related Terms
LataMed AI Market Cap Historical Data
* Premium members only.
The historical data trend for LataMed AI's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Software - Application subindustry, LataMed AI's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LataMed AI Market Cap vs Software Industry
For the Software industry and Technology sector, LataMed AI's Market Cap distribution charts can be found below:
* The bar in red indicates where LataMed AI's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
LataMed AI's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LataMed AI (LMEDD) has a Market Cap of $1,574.42 Mil as of Jul. 17, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on LataMed AI and its competitors. According to the industry distribution chart, LataMed AI ranks #376 out of 2932 companies in the Software industry, placing it in the top 12.8%.
Is LataMed AI's Market Cap too high?
LataMed AI's current Market Cap is $1,574.42 Mil. The Software industry median Market Cap is 67.23. LataMed AI's value of $1,574.42 Mil is 2241.9% above this industry median. Based on the distribution chart, LataMed AI ranks #376 out of 2932 companies in the Software industry, which is in the top quartile — a strong position relative to peers. Overall, LataMed AI has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does LataMed AI's Market Cap compare to KLTR and BZAI?
According to the Software industry distribution chart, LataMed AI ranks #376 out of 2932 companies for Market Cap. This places LataMed AI in the top 13% of its industry — outperforming the majority of peers. The industry median Market Cap is 67.23. LataMed AI's value of $1,574.42 Mil is 2241.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Software company?
The median Market Cap among Software companies is 67.23, based on 2,932 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LataMed AI's current Market Cap of $1,574.42 Mil is 2241.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on LataMed AI and its competitors. For the Software industry, the median Market Cap is 67.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LataMed AI's current Market Cap is $1,574.42 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LataMed AI stock overvalued right now?
LataMed AI (LMEDD) has a current Market Cap of $1,574.42 Mil. The current Market Cap is $1,574.42 Mil and 2241.9% above the Software industry median of 67.23. LataMed AI's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For LataMed AI (LMEDD), the current Market Cap is $1,574.42 Mil as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
LataMed AI Corp is a technology company focused on the development and deployment of artificial intelligence-driven healthcare solutions across Latin America. Its healthcare platform includes AI-enabled analytics, telehealth infrastructure, and coordinated care systems designed to support healthcare delivery in emerging markets. The company develops digital infrastructure for patient prioritization, clinical workflow management, telehealth access, care coordination, and healthcare system operations. It holds issued patents for its core AI modules-CardioAI, PulmoAI, and NeuroAI-which deliver predictive analytics for cardiovascular, pulmonary, and neurological disease detection and management.
26GF Score
Get the complete analysis for LMEDD
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LMEDD has been successfully added to your 
